Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2012

01.07.2012 | Article

Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii

verfasst von: J. Moran-Gilad, D. Schwartz, S. Navon-Venezia, Y. Carmeli

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Microbiological surveillance for detection of carbapenem-resistant A. baumannii is important, but recovery of A. baumannii is inadequate. We studied A. baumannii recovery by a particular transport system that is possibly superior over standard swabs, using reference and clinical strains. First, the recovery rates relating to the various swabs were compared with regard to various combinations of transport times (0 h, 1 h, 24 h, 48 h), storage times (0 weeks, 1 week, 2 weeks, 4 weeks) and storage temperatures (4°c,−80°c) using live counts. Second, the recovery of different inocula of strains mixed with fecal microbiota was evaluated by plating on selective medium. The new transport system exhibited a decline of <3log10 under almost all conditions studied and performed better than standard swabs under several conditions. If plated on selective media, the new transport system performed well, even after prolonged transport or with a low inoculum, and its processing could be delayed by up to 2 weeks, especially if refrigerated. The new transport system may thus enhance A. baumannii surveillance.
Literatur
1.
Zurück zum Zitat Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, Porath A, Rimar D, Almog Y, Gilad J (2003) Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54:32–38PubMedCrossRef Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, Porath A, Rimar D, Almog Y, Gilad J (2003) Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54:32–38PubMedCrossRef
2.
Zurück zum Zitat Gilad J, Carmeli Y (2008) Management of multi-drug resistant Acinetobacter spp. Drugs 68:165–189PubMedCrossRef Gilad J, Carmeli Y (2008) Management of multi-drug resistant Acinetobacter spp. Drugs 68:165–189PubMedCrossRef
3.
Zurück zum Zitat Marchaim D, Navon-Venezia S, Schwarz D, Tarabeia J, Fefer I, Schwaber MJ, Carmeli Y (2007) Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 45:1551–1555PubMedCrossRef Marchaim D, Navon-Venezia S, Schwarz D, Tarabeia J, Fefer I, Schwaber MJ, Carmeli Y (2007) Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 45:1551–1555PubMedCrossRef
4.
Zurück zum Zitat Dalben MF, Oliviera MS, Garcia CP, Lobo RD, Costa SF, Toscano CM, Levin AS (2010) Swab cultures across three different body sites among carriers of carbapenem-resistant P. Aeruginosa and Acinetobacter species: a poor surveillance strategy. J Hosp Infect 74:395–396PubMedCrossRef Dalben MF, Oliviera MS, Garcia CP, Lobo RD, Costa SF, Toscano CM, Levin AS (2010) Swab cultures across three different body sites among carriers of carbapenem-resistant P. Aeruginosa and Acinetobacter species: a poor surveillance strategy. J Hosp Infect 74:395–396PubMedCrossRef
5.
Zurück zum Zitat Furuno JP, Hebden JN, Standiford HC, Perencevich EN, Miller RM, Moore AC, Strauss SM, Harris AD (2008) Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 36:468–471PubMedCrossRef Furuno JP, Hebden JN, Standiford HC, Perencevich EN, Miller RM, Moore AC, Strauss SM, Harris AD (2008) Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 36:468–471PubMedCrossRef
6.
Zurück zum Zitat Yohei D, Onuoha EO, Adams-Haduch JM, Pakstis DL, McGaha TL, Werner CA, Parker CN, Brooks MM, Shutt KA, Pasculle AW, Muto CA, Harrison LH (2011) Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 49:154–158CrossRef Yohei D, Onuoha EO, Adams-Haduch JM, Pakstis DL, McGaha TL, Werner CA, Parker CN, Brooks MM, Shutt KA, Pasculle AW, Muto CA, Harrison LH (2011) Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 49:154–158CrossRef
7.
Zurück zum Zitat Clinical and Laboratory Standards Institute (2003) Quality control of microbiological transport systems; approved standard, CLSI M40-A. Clinical and Laboratory Standards Institute, Wayne, PA Clinical and Laboratory Standards Institute (2003) Quality control of microbiological transport systems; approved standard, CLSI M40-A. Clinical and Laboratory Standards Institute, Wayne, PA
8.
Zurück zum Zitat Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y (2011) Laboratory and clinical evaluation of screening agar plates for the detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol 49:2239–2242PubMedCrossRef Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y (2011) Laboratory and clinical evaluation of screening agar plates for the detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol 49:2239–2242PubMedCrossRef
9.
Zurück zum Zitat Nys S, Vijgen S, Magerman K, Cartuyvels R (2010) Comparison of Copan ESwab with the Copan Venturi Transystem for the quantitative survival of Escherichia coli, Streptococcus agalactiae and Candida albicans. Eur J Clin Microbiol Infect Dis 29:453–546PubMedCrossRef Nys S, Vijgen S, Magerman K, Cartuyvels R (2010) Comparison of Copan ESwab with the Copan Venturi Transystem for the quantitative survival of Escherichia coli, Streptococcus agalactiae and Candida albicans. Eur J Clin Microbiol Infect Dis 29:453–546PubMedCrossRef
10.
Zurück zum Zitat Van Horn KG, Audette CD, Sebeck D, Tucker KA (2008) Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability. J Clin Microbiol 46:1655–1658PubMedCrossRef Van Horn KG, Audette CD, Sebeck D, Tucker KA (2008) Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability. J Clin Microbiol 46:1655–1658PubMedCrossRef
11.
Zurück zum Zitat Van Horn KG, Audette CD, Tucker KA, Sebeck D (2008) Comparison of 3swab transport systems for direct release and recovery of aerobic and anaerobic bacteria. Diag Microbiol Infect Dis 62:471–473CrossRef Van Horn KG, Audette CD, Tucker KA, Sebeck D (2008) Comparison of 3swab transport systems for direct release and recovery of aerobic and anaerobic bacteria. Diag Microbiol Infect Dis 62:471–473CrossRef
12.
Zurück zum Zitat Smismans A, Verhaegen J, Schuermans A, Frans J (2009) Evaluation of the Copan ESwab transport system for the detection of methicillin-resistant Staphylococcus aureus: a laboratory and clinical study. Diag Microbiol Infect Dis 65:108–111CrossRef Smismans A, Verhaegen J, Schuermans A, Frans J (2009) Evaluation of the Copan ESwab transport system for the detection of methicillin-resistant Staphylococcus aureus: a laboratory and clinical study. Diag Microbiol Infect Dis 65:108–111CrossRef
13.
Zurück zum Zitat Fontana C, Favaro M, Limongi D, Pivonkova J, Favalli C (2009) Comparison of the ESwab collection and transportation system to an amies gel transystem for gram stain of clinical specimens. BMC Res Notes 2:244PubMedCrossRef Fontana C, Favaro M, Limongi D, Pivonkova J, Favalli C (2009) Comparison of the ESwab collection and transportation system to an amies gel transystem for gram stain of clinical specimens. BMC Res Notes 2:244PubMedCrossRef
14.
Zurück zum Zitat Borer A, Gilad J, Porat N, Megreleshvilli R, Saidel-Odes L, Peled N, Eskira S, Schlaeffer F, Almog Y (2007) Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive-care unit. J Hosp Infect 67:149–155PubMedCrossRef Borer A, Gilad J, Porat N, Megreleshvilli R, Saidel-Odes L, Peled N, Eskira S, Schlaeffer F, Almog Y (2007) Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive-care unit. J Hosp Infect 67:149–155PubMedCrossRef
Metadaten
Titel
Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii
verfasst von
J. Moran-Gilad
D. Schwartz
S. Navon-Venezia
Y. Carmeli
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1460-2

Weitere Artikel der Ausgabe 7/2012

European Journal of Clinical Microbiology & Infectious Diseases 7/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.